Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension

Hypertension

Volumn 44, Issue 2, 2004, Pages 163-169

  San José, Gorka ^a   Moreno, María U ^a   Oliván, Sara ^a   Beloqui, Oscar ^b   Fortuño, Ana ^a   Díez, Javier ^a,b   Zalba, Guillermo ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Hypertension, arterial; Oxidative stress; Polymorphism

Indexed keywords

PROTEIN P22; PROTEIN P22 PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYBA PROTEIN, HUMAN; LUCIFERASE; NITRIC OXIDE; PHOSPHOPROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BIOAVAILABILITY; CELL INTERACTION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; CELL LINE; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GENES, REPORTER; GENOTYPE; HUMANS; HYPERTENSION; LUCIFERASES; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NADPH DEHYDROGENASE; NADPH OXIDASE; NITRIC OXIDE; OXIDATIVE STRESS; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 3543011345     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000134790.02026.e4     Document Type: Article

References (36)

1. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension, 2003;42:1075-1081.
2. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995; 25:155-161.
3. Cai H, Harrison DG, Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
4. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
5. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568-H2572.
6. Pagano P, Ito Y, Tomheim K, Gallop P, Tauber A, Cohen R. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol. 1995;268:H2274-H2280.
7. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
8. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317-23321.
9. Zalba G, Beaumont FJ, San José G, Fortuño A, Fortuño MA, Etayo JC, Díez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension. 2000;35:1055-1061.
10. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. P22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51.
11. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 2001;38:1107-1111.
12. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens. 2001;19:1245-1254.
13. Dinauer MC, Pierce EA, Bruns GAP, Cumutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990;86:1729-1737.
14. Cross AR, Noack D, Rae J, Heyworth PG. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease. Blood Cells Mol Dis. 2000;26:561-565.
15. phox gene in vascular smooth muscle cells from SHR. Circ Res. 2001;88:217-222.
16. Moreno MU, San Jose G, Orbe J, Paramo JA, Beloqui O, Díez J, Zalba G. Preliminary characterisation of the promoter of the human p22phox gene: identification of a new polymorphism associated with hypertension. FEBS Lett. 2003;542:27-31.
17. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res. 2001;89:224-236.
18. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension. 1995;25:848-853.
19. Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation. 2001;104:1767-1772.
20. Lee HS, Son SM, Kim YK, Hong KW, Kim CD. NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells. Life Sci. 2003;72:2719-2730.
21. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation. 2003;108:1253-1258.
22. Kitami Y, Fukuoka T, Hiwada K, Inagami T. A high level of CCAAT-enhancer binding protein-delta expression is a major determinant for markedly elevated differential gene expression of the platelet-derived growth factor-alpha receptor in vascular smooth muscle cells of genetically hypertensive rats. Circ Res. 1999;84:64-73.
23. Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, Brown CD, Ott J, Kumar A. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem. 2002;277:36889-36896.
24. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem. 1998;273:29279-29282.
25. Dörffel Y, Lätsch C, Stuhlmüller B, Schreiber S, Scholze S, Burmester GR, Scholze J. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension. 1999;34:113-117.
26. Moreno MU, San José G, Díez J, Zalba G. Polymorphisms in the promoter region of the human p22phox gene. Hypertension. 2001;38:979. Abstract.
27. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Díez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension. 2001;38:1395-1399.
28. Pettit AI, Wong RKM, Lee V, Jennings S, Quinn PA, Ng LL. Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22phox in lymphoblast cell lines. J Hypertens. 2002;20:677-683.
29. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201-1209.
30. Suzuki H, Delano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifac BW, Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1998;54:775-784.
31. Redón J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Sáez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003;41:1096-1101.
32. Hilgers KF. Monocytes/macrophages in hypertension. J Hypertens. 2002; 20:593-596.
33. Dorffel Y, Franz S, Pruss A, Neumann G, Rohde W, Burmester GR, Scholze J. Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?. Atherosclerosis. 2001;157:151-160.
34. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435.
35. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Chanon KM. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation. 2000;102:1744-1747.
36. Dusi S, Donini M, Lisandrini D, Mazzi P, Della Bianca V, Rossi F. Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytokines and transcriptional regulators involved. Eur J Immunol. 2001;31:929-938.